Hospital Clinico Universitario de Valladolid
Valladolid 47010
7 studies enrolling now · 27 studies all time
What they study most
Acute Ischemic Stroke, Acute Myocardial Infarction, Acute Treatment of Migraine, Arteriosclerosis, Atrial Fibrillation, Brain Edema, Cardiovascular Diseases, Chronic Total Occlusion, Chronic Total Occlusion of Coronary Artery, Coronary Artery Disease, Coronary Disease, Early Breast Cancer
Studies at this site
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
- Adjuvant Tebentafusp in High Risk Ocular Melanoma — Recruiting now
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
- An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
- Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications — Completed
- Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
- Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery — Completed
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures — Stopped early
- Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
- A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease. — Stopped early
- A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache — Completed
- Sapphire 3 CTO Study — Completed
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
- Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
- A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
- Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation — Stopped early
- Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
- Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke — Completed
- A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
- Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
- Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke — Stopped early